Alternative Data for Pacific Biosciences of California
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 9 | Sign up | Sign up | Sign up |
| Sentiment | 67 | Sign up | Sign up | Sign up |
| Webpage traffic | 97,000 | Sign up | Sign up | Sign up |
| Employee Rating | 60 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 2 | Sign up | Sign up | Sign up |
| Facebook Followers | 5,202 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 33 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 14,329 | Sign up | Sign up | Sign up |
| X Followers | 44,782 | Sign up | Sign up | Sign up |
| X Mentions | 1 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 6,480 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 23 | Sign up | Sign up | Sign up |
| Linkedin Employees | 591 | Sign up | Sign up | Sign up |
About Pacific Biosciences of California
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems.
| Price | $1.12 |
| Target Price | Sign up |
| Volume | 9,870,271 |
| Market Cap | $348M |
| Year Range | $1.12 - $2.67 |
| Dividend Yield | 0% |
| Analyst Rating | 43% buy |
| Industry | Medical Devices |
In the news
Pacific Biosciences of California, Inc. 2025 Q4 - Results - Earnings Call PresentationFebruary 13 - SeekingAlpha |
|
 |
Pacific Biosciences of California, Inc. (PACB) Q4 2025 Earnings Call TranscriptFebruary 13 - SeekingAlpha |
 |
PACIFIC BIOSCIENCES OF CALIF (NASDAQ:PACB) Beats Q4 2025 Revenue and EPS EstimatesFebruary 12 - ChartMill |
|
Pacific Biosciences of California, Inc. (PACB) Presents at 44th Annual J.P. Morgan Healthcare Conference - SlideshowJanuary 12 - SeekingAlpha |
Pacific Biosciences of California, Inc. (PACB) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptJanuary 11 - SeekingAlpha |
|
How PacBio (PACB) Is Seeing Its Fair Value Story Shift After ARK’s Share PurchaseJanuary 10 - Yahoo Entertainment |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '26 | 37M | 24M | 13M | -8.3M | -38M | 0.000 |
| Q4 '25 | 45M | 28M | 17M | -40M | -38M | -0.120 |
| Q3 '25 | 38M | 23M | 15M | -38M | -34M | -0.120 |
| Q2 '25 | 40M | 25M | 15M | -42M | -36M | -0.130 |
| Q1 '25 | 37M | 39M | -1.4M | -426M | -52M | -0.150 |
Insider Transactions View All
| Gibson James R II filed to sell 1,245,663 shares at $1.4. April 3 '26 |
| Farmer Michele filed to sell 305,948 shares at $1.5. March 4 '26 |
| Van Oene Mark filed to sell 2,243,634 shares at $1.5. March 4 '26 |
| HENRY CHRISTIAN O filed to sell 3,581,813 shares at $1.5. March 4 '26 |
| Farmer Michele filed to sell 219,092 shares at $1.6. February 19 '26 |
Similar companies
Read more about Pacific Biosciences of California (PACB) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, reddit mentions, stocktwits mentions, stocktwits subscribers, x followers, x mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
FAQ - Pacific Biosciences of California
The Market Cap of Pacific Biosciences of California is $348M.
Currently, the price of one share of Pacific Biosciences of California stock is $1.12.
The PACB stock price chart above provides a comprehensive visual representation of Pacific Biosciences of California's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Pacific Biosciences of California shares. Our platform offers an up-to-date PACB stock price chart, along with technical data analysis and alternative data insights.
As of our latest update, Pacific Biosciences of California (PACB) does not offer dividends to its shareholders. Investors interested in Pacific Biosciences of California should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
Some of the similar stocks of Pacific Biosciences of California are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.
